• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

长链非编码 RNA PTCSC3 通过下调 lncRNA H19 抑制三阴性乳腺癌细胞增殖。

LncRNA PTCSC3 inhibits triple-negative breast cancer cell proliferation by downregulating lncRNA H19.

机构信息

Department of Pathology, Shaoxing Hospital of Traditional Chinese Medicine, Shaoxing, Zhejiang, P.R. China.

出版信息

J Cell Biochem. 2019 Sep;120(9):15083-15088. doi: 10.1002/jcb.28769. Epub 2019 Apr 26.

DOI:10.1002/jcb.28769
PMID:31026090
Abstract

Long noncoding RNA (lncRNA) PTCSC3 (hereafter PTCSC3 is used to represent lncRNA PTCSC3) inhibits glioma and thyroid cancer, indicating its potential tumor suppression function in other types of cancers. We explored the potential involvement of PTCSC3 in triple-negative breast cancer (TNBC). In the current study, we found that PTCSC3 was downregulated in tumor tissues of patients with TNBC. PTCSC3 expression was positively correlated with plasma levels of PTCSC3. LncRNA H19 was upregulated and was inversely correlated with PTCSC3 in tumor tissues. PTCSC3 overexpression led to downregulated H19 in TNBC cells, while H19 overexpression did not affect PTCSC3 expression. PTCSC3 inhibited and H19 promoted proliferation of TNBC cells. H19 overexpression attenuated the effects of PTCSC3 overexpression. Cancer cell migration and invasion were not significantly affected by PTCSC3 overexpression. Therefore, lncRNA PTCSC3 inhibits TNBC cell proliferation by downregulating lncRNA H19.

摘要

长链非编码 RNA (lncRNA) PTCSC3(以下简称 PTCSC3 用于代表 lncRNA PTCSC3)抑制神经胶质瘤和甲状腺癌,表明其在其他类型癌症中具有潜在的肿瘤抑制功能。我们探讨了 PTCSC3 参与三阴性乳腺癌 (TNBC) 的潜在作用。在本研究中,我们发现 PTCSC3 在 TNBC 患者的肿瘤组织中表达下调。PTCSC3 的表达与 PTCSC3 的血浆水平呈正相关。在肿瘤组织中,lncRNA H19 上调且与 PTCSC3 呈负相关。PTCSC3 过表达导致 TNBC 细胞中 H19 下调,而 H19 过表达不影响 PTCSC3 的表达。PTCSC3 抑制 TNBC 细胞的增殖,而 H19 促进 TNBC 细胞的增殖。H19 过表达减弱了 PTCSC3 过表达的作用。PTCSC3 过表达对癌细胞的迁移和侵袭没有显著影响。因此,lncRNA PTCSC3 通过下调 lncRNA H19 抑制 TNBC 细胞的增殖。

相似文献

1
LncRNA PTCSC3 inhibits triple-negative breast cancer cell proliferation by downregulating lncRNA H19.长链非编码 RNA PTCSC3 通过下调 lncRNA H19 抑制三阴性乳腺癌细胞增殖。
J Cell Biochem. 2019 Sep;120(9):15083-15088. doi: 10.1002/jcb.28769. Epub 2019 Apr 26.
2
LncRNA PTCSC3 inhibits cell proliferation in laryngeal squamous cell carcinoma by down-regulating lncRNA HOTAIR.长链非编码 RNA PTCSC3 通过下调长链非编码 RNA HOTAIR 抑制喉鳞状细胞癌中的细胞增殖。
Biosci Rep. 2019 Jun 28;39(6). doi: 10.1042/BSR20182362.
3
LncRNA NEF is downregulated in triple negative breast cancer and correlated with poor prognosis.长链非编码 RNA NEF 在三阴性乳腺癌中下调,与预后不良相关。
Acta Biochim Biophys Sin (Shanghai). 2019 Apr 1;51(4):386-392. doi: 10.1093/abbs/gmz021.
4
Long noncoding RNA papillary thyroid carcinoma susceptibility candidate 3 (PTCSC3) inhibits proliferation and invasion of glioma cells by suppressing the Wnt/β-catenin signaling pathway.长链非编码RNA甲状腺乳头状癌易感候选基因3(PTCSC3)通过抑制Wnt/β-连环蛋白信号通路抑制胶质瘤细胞的增殖和侵袭。
BMC Neurol. 2017 Feb 10;17(1):30. doi: 10.1186/s12883-017-0813-6.
5
LncRNA NRON down-regulates lncRNA snaR and inhibits cancer cell proliferation in TNBC.长链非编码 RNA NRON 下调 snaR 并抑制三阴性乳腺癌中的癌细胞增殖。
Biosci Rep. 2019 May 14;39(5). doi: 10.1042/BSR20190468. Print 2019 May 31.
6
Long non‑coding RNA PTCSC3 suppresses triple‑negative breast cancer by downregulating long non‑coding RNA MIR100HG.长链非编码RNA PTCSC3通过下调长链非编码RNA MIR100HG抑制三阴性乳腺癌。
Oncol Lett. 2023 Jun 15;26(2):331. doi: 10.3892/ol.2023.13917. eCollection 2023 Aug.
7
LncRNA AWPPH and miRNA-21 regulates cancer cell proliferation and chemosensitivity in triple-negative breast cancer by interacting with each other.长链非编码 RNA AWPPH 通过与 miRNA-21 相互作用调节三阴性乳腺癌中癌细胞的增殖和化疗敏感性。
J Cell Biochem. 2019 Sep;120(9):14860-14866. doi: 10.1002/jcb.28747. Epub 2019 Apr 29.
8
LncRNA WT1-AS Inhibits Triple-Negative Breast Cancer Cell Migration and Invasion by Downregulating Transforming Growth Factor β1.长链非编码 RNA WT1-AS 通过下调转化生长因子 β1 抑制三阴性乳腺癌细胞迁移和侵袭。
Cancer Biother Radiopharm. 2019 Dec;34(10):671-675. doi: 10.1089/cbr.2019.2925. Epub 2019 Oct 17.
9
LncRNA PTCSC3 Is a Biomarker for the Treatment and Prognosis of Gastric Cancer.长链非编码RNA PTCSC3是胃癌治疗和预后的生物标志物。
Cancer Biother Radiopharm. 2020 Feb;35(1):77-81. doi: 10.1089/cbr.2019.2991. Epub 2019 Nov 8.
10
LncRNA TCONS_l2_00002973 correlates with less advanced tumor stage and favorable survival, and also inhibits cancer cells proliferation while enhancing apoptosis in triple-negative breast cancer.长链非编码RNA TCONS_l2_00002973与较低的肿瘤分期和良好的生存率相关,并且在三阴性乳腺癌中还能抑制癌细胞增殖,同时增强细胞凋亡。
J BUON. 2019 Mar-Apr;24(2):535-542.

引用本文的文献

1
The Role of Long Non-Coding RNAs in Modulating the Immune Microenvironment of Triple-Negative Breast Cancer: Mechanistic Insights and Therapeutic Potential.长链非编码RNA在调节三阴性乳腺癌免疫微环境中的作用:机制见解与治疗潜力
Biomolecules. 2025 Mar 20;15(3):454. doi: 10.3390/biom15030454.
2
Long non-coding RNA involved in the carcinogenesis of human female cancer - a comprehensive review.参与人类女性癌症致癌过程的长链非编码RNA——综述
Discov Oncol. 2025 Feb 6;16(1):122. doi: 10.1007/s12672-025-01848-1.
3
The mechanism underlying metastasis in triple-negative breast cancer: focusing on the interplay between ferroptosis, epithelial-mesenchymal transition, and non-coding RNAs.
三阴性乳腺癌转移的潜在机制:聚焦于铁死亡、上皮-间质转化和非编码RNA之间的相互作用。
Front Pharmacol. 2025 Jan 15;15:1437022. doi: 10.3389/fphar.2024.1437022. eCollection 2024.
4
Targeted therapy approaches for epithelial-mesenchymal transition in triple negative breast cancer.三阴性乳腺癌上皮-间质转化的靶向治疗方法
Front Oncol. 2024 Oct 10;14:1431418. doi: 10.3389/fonc.2024.1431418. eCollection 2024.
5
Decreased levels of PTCSC3 promote the deterioration of prostate cancer and affect the prognostic outcome of patients through sponge miR-182-5p.PTCSC3 水平降低通过海绵 miR-182-5p 促进前列腺癌的恶化,并影响患者的预后结果。
BMC Urol. 2024 Jul 12;24(1):144. doi: 10.1186/s12894-024-01531-7.
6
Human bone marrow mesenchymal stem cell-driven LncRNA PTCSC3 upregulation within lung adenocarcinoma cells reduces erlotinib resistance by mitigating Wnt/β-Catenin pathway.人骨髓间充质干细胞驱动肺癌腺癌细胞内LncRNA PTCSC3上调,通过减轻Wnt/β-连环蛋白信号通路降低厄洛替尼耐药性。
Am J Cancer Res. 2024 May 15;14(5):2439-2452. doi: 10.62347/BOFP2157. eCollection 2024.
7
Role of ferroptosis and ferroptosis-related long non'coding RNA in breast cancer.铁死亡及铁死亡相关长非编码 RNA 在乳腺癌中的作用。
Cell Mol Biol Lett. 2024 Mar 26;29(1):40. doi: 10.1186/s11658-024-00560-2.
8
Harnessing the potential of long non-coding RNAs in breast cancer: from etiology to treatment resistance and clinical applications.挖掘长链非编码RNA在乳腺癌中的潜力:从病因到治疗耐药性及临床应用
Front Oncol. 2024 Mar 5;14:1337579. doi: 10.3389/fonc.2024.1337579. eCollection 2024.
9
Roles of lncRNA in the diagnosis and prognosis of triple-negative breast cancer.长链非编码 RNA 在三阴性乳腺癌诊断和预后中的作用。
J Zhejiang Univ Sci B. 2023 Dec 15;24(12):1123-1140. doi: 10.1631/jzus.B2300067.
10
Roles of long noncoding RNA in triple-negative breast cancer.长链非编码 RNA 在三阴性乳腺癌中的作用。
Cancer Med. 2023 Oct;12(20):20365-20379. doi: 10.1002/cam4.6600. Epub 2023 Oct 5.